ABCuro finishes enrolling participants for phase 2/3 IBM treatment trial – Pharmafile
Abcuro, a company specializing in musculoskeletal disorders, has recently completed enrollment for its MUSCLE registration phase 2/3 clinical trial. This…
Virtual Machine News Platform
Abcuro, a company specializing in musculoskeletal disorders, has recently completed enrollment for its MUSCLE registration phase 2/3 clinical trial. This…